Skip to main content
. 2022 Sep 3;18(2):470–476. doi: 10.1177/19322968221121660

Table 1.

Classification of Positive Care Effects of DiGA the Proof of Which Is a Prerequisite for the Reimbursement of Costs by the Statutory Heath Insurers in Germany.

Positive care effects
Medical benefits Patient-relevant structure and procedure improvements
Improving health status More effective coordination of treatment procedures
Shortening the duration of the disease Closer alignment of treatments with guidelines and recognized standards
Prolongation of survival Improved treatment adherence
Improved quality of life Easier access to care
Improved patient safety
Better health literacy
Patient sovereignty
Better coping with illness-related everyday problems
Reduction of therapy-related efforts and burdens for patients and their relatives

A special focus is on the patient-centering of the positive effects that must be demonstrated to the Federal Institute for Drugs and Medical Devices (BfArM) by the manufacturer. The workload of medical professionals or health or health economic indicators are not classified as patient-relevant endpoints in this context. 6

Abbreviation: DiGA, Digital Health Applications.